R Michael Carruthers's Net Worth

$1.85 Million

Estimate Recalculated Nov 1, 2024 02:23PM EST

Who is R Michael Carruthers

R Michael Carruthers has an estimated net worth of $1.85 Million. This is based on reported shares across multiple companies, which include Nivalis Therapeutics, Inc., Edgewise Therapeutics, Inc., Elevation Oncology, Inc., and Brickell Biotech, Inc..

SEC CIK

R Michael Carruthers's CIK is 0001644467

Past Insider Trading and Trends

2024 was R Michael Carruthers's most active year for acquiring shares with 5 total transactions. R Michael Carruthers's most active month to acquire stocks was the month of July. 2024 was R Michael Carruthers's most active year for disposing of shares, totalling 4 transactions. R Michael Carruthers's most active month to dispose stocks was the month of April. 2024 saw R Michael Carruthers paying a total of $173,700.00 for 292,083 shares, this is the most they've acquired in one year. In 2024 R Michael Carruthers cashed out on 187,365 shares for a total of $1,460,547.87, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Nivalis Therapeutics, Inc.

Interim President / CFO
Updated Jan 23, 2017
Form 4
200.00K
Jan 23, 2017
200.00K
Grant
Jan 12
Form 4
24.00K
$2.09
$50.26K
Dec 05, 2016
24.00K
Purchase
Dec 02
Form 4
110.00K
Sep 14, 2016
110.00K
Grant
Sep 12
Form 4
55.40K
Sep 15, 2015
55.40K
Grant
Sep 11
Form 3
Jun 16, 2015
Showing 5 results

Edgewise Therapeutics, Inc.

Chief Financial Officer
Updated Oct 16, 2024
Form 4
$0.71
$49.70K
Oct 16, 2024
204.03K
Options
Oct 11
Form 4
161.88K
Aug 14, 2024
161.88K
Grant
Aug 12
Form 4
-5.06%
-2.16K
$18.91
-$40.79K
May 03, 2024
40.44K
Sale
May 01 - May 02
Form 4
-35.14%
-90.00K
$8.86
-$1.25M
Jan 25, 2024
166.08K
Sale
Jan 23
Form 4
200.00K
Aug 18, 2023
200.00K
Grant
Aug 17
Form 4
$0.71
$7.10K
Jun 26, 2023
226.15K
Options
Jun 22
Form 4
-4.79%
-1.34K
$8.90
-$11.90K
May 03, 2023
26.54K
Sale
May 01 - May 02
Form 4
200.00K
Aug 10, 2022
200.00K
Grant
Aug 08
Form 4
$0.71
May 25, 2022
219.12K
Options
May 23
Form 4
15.63K
May 03, 2022
15.63K
Grant
May 01
Form 4
120.00K
Aug 19, 2021
120.00K
Grant
Aug 17
Form 3
Mar 25, 2021
Showing 12 results

Elevation Oncology, Inc.

Investor
Updated Jun 17, 2024
Form 4
35.00K
Jun 17, 2024
35.00K
Grant
Jun 13
Form 4
31.24K
Jun 21, 2023
31.24K
Grant
Jun 16
Form 4
15.62K
Jun 22, 2022
15.62K
Grant
Jun 17
Form 3
Jun 24, 2021
Showing 4 results

Brickell Biotech, Inc.

Chief Financial Officer
Updated Mar 18, 2020
Form 4
10.00K
$1.54
$15.40K
Mar 18, 2020
55.81K
Grant
Mar 16
Form 3
Sep 09, 2019
Showing 2 results